Longitudinal analysis of serum cytokines in a Behcet's patient during 9 months of IVIG infusions: how does CXCL8 bridge the immune and neuroendocrine systems?
暂无分享,去创建一个
C. Tinelli | M. Di Stefano | L. Scudeller | G. Emmi | C. Capittini | E. Antoniazzi | M. De Amici | N. Aronico
[1] Rosanna Abbate,et al. Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet Disease , 2016, Circulation.
[2] M. Bozkurt,et al. Serum Cytokine Levels in Behçet's Disease , 2015, Journal of clinical laboratory analysis.
[3] F. D’Acquisto,et al. ‘As above, so below’ examining the interplay between emotion and the immune system , 2014, Immunology.
[4] P. Sfikakis,et al. Anti-cytokine biologic treatment beyond anti-TNF in Behçet's disease. , 2014, Clinical and experimental rheumatology.
[5] M. D’Elios,et al. Behçet’s syndrome pathophysiology and potential therapeutic targets , 2014, Internal and Emergency Medicine.
[6] P. Cacoub,et al. Approaches to immunosuppression in Behçet's disease. , 2013, Immunotherapy.
[7] H. Kikuchi,et al. Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Behçet's disease. , 2012, Internal medicine.
[8] T. Ergun,et al. Neutrophil activation in Behçet's disease. , 2001, Clinical and experimental rheumatology.
[9] C. Zouboulis,et al. Adamantiades-Behçet’s Disease: Serum IL-8 Is a More Reliable Marker for Disease Activity than C-Reactive Protein and Erythrocyte Sedimentation Rate , 2000, Dermatology.
[10] C. Zouboulis,et al. Adamantiades-Behçet’s disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells , 2000, Archives of Dermatological Research.
[11] A. Silman,et al. [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.